We help Support at Home-approved families find care.
Aged Care Home
Support at Home
Retirement Living
Finance & Placement Advice
Healthcare Equipment
Mobility and Equipment
Patient care equipment
Skin and wound Care
Safety and Security
Assessments
Assistive Technology
End of Life
Financial Services
Funerals
Placement Consultants
Advocacy
No results found
No results found
No results found
Advanced Filters
Distance (proximity)
Price Range
RAD (Refundable Accommodation Deposit) is a lump-sum payment for aged care homes. It is fully refundable when the resident leaves, as long as there are no outstanding fees.
Min RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Maximum RAD
Any
$250,000
$500,000
$750,000
$1,000,000
$1,500,000
$1,750,000
$2,000,000
Facility size
Based on how many beds the facilty has.
Any
Small
Medium
Large
Service Delivery
Services offered at a location or in a region
Any
On Site
Service Region
Features
Single rooms with ensuites
Respite beds
Extra service beds
Secure dementia beds
24/7 Registered nursing
Full or Partially government funded
Couples accommodation
Facility has pets
Non-dedicated respite
Palliative care
Partner considered without ACAT
Secure garden
Transition care
Cafe/Kiosk
Chapel/Church
Hairdressing Salon
Facility Owned Transport
Single Rooms
Rooms with ensuites
Registered nursing
Non secure dementia care
Diversional therapy
Medication supervision
Respite care
Secure access
Small pets considered

Parkinson’s patients have double the risk of melanoma

Parkinson’s disease patients have double the risk of developing potentially lethal melanoma, researchers reported on Tuesday (7 June 2011). Researchers have long suspected such a link, but the new study, reported in the journal Neurology, provides the strongest evidence to date.

Posted
by DPS

Parkinson’s disease patients have double the risk of developing potentially lethal melanoma, researchers reported on Tuesday (7 June 2011). Researchers have long suspected such a link, but the new study, reported in the journal Neurology, provides the strongest evidence to date.

While researchers are at a loss to explain how the link occurs biologically, they suspect it may be a combination of environmental exposure and genetic predisposition.

Experts say the discovery is particularly “strange” because Parkinson’s patients, in general, have a below-normal risk of developing most types of cancer.

Establishing a link between Parkinson’s and melanoma is difficult because both are relatively rare diseases.

To increase the chances of finding statistically significant results, Dr Honglei Chen, a neuroscientist at the National Institute of Environmental Health Sciences in Research Triangle Park, New York City, and colleagues combined the results from 12 studies conducted between 1965 and 2010.

Overall, the researchers found the risk of melanoma was 2.11 times normal in Parkinson’s patients.

The team found the risk of melanoma was 2.04 times normal for men and 1.52 times normal for women.

The risk of diagnosis of melanoma was significantly higher after Parkinson’s had been diagnosed. The team found no link to non-melanoma skin cancers.

Many experts had thought the increased risk of melanoma was produced by levo-dopa, the most common treatment for Parkinson’s disease.

But Dr Chen discarded the link, and suggested the same high risk of melanoma is associated with patients who have not received the drug.

Some studies have shown pigmentation might also contribute to the risk of melanoma, as lighter hair colour is associated with an increased risk of Parkinson’s and of melanoma.

However, researchers concluded further research was needed to clarify the link between the two diseases.

Read next

Sign up or log in with your phone number
Phone
Enter your phone number to receive a verification notification
Aged Care Guide is endorsed by
COTA logo
ACIA logo